Hyperhomocysteinemia and stroke pdf

Spontaneous isolated posterior communicating artery. Plasma hcy and amino acids were measured by fluorescence polarization immune assay and ion exchange chromatography. Hyperhomocysteinemia is a medical condition characterized by an abnormally high level of homocysteine in the blood, conventionally described as above 15 moll as a consequence of the biochemical reactions in which homocysteine is involved, deficiencies of vitamin b 6, folic acid vitamin b 9, and vitamin b 12 can lead to high homocysteine levels. Frequency of homocysteinemia in young ischemic stroke.

Although hyperhomocysteinemia hyperhcy may predispose to atherosclerosis and venous thrombosis, the mechanisms of stroke associated with hyperhcy are not defined. On further evaluation, thrombophilia profile showed increased. Impaired homocysteine metabolism and atherothrombotic. Patients with hyperhomocysteinemia hhcy have a higher risk of developing ischemic stroke is. We welcome the report from madonna and coworkers examining the role of prothrombotic and homocysteine hcy pathway polymorphisms in risk of ischemic stroke in young adults. Hyperhomocysteinemia, ischemic stroke, and bvitamin. A stroke can be either an ischemic or hemorrhagic event that disturbs the blood flow to part of the brain, such as via the occlusion or rupture of a blood vessel. It is reported that csvd can cause 20% of ischemic strokes and 45% of dementia. The study found that the stroke victims had higher homocysteine levels in general, and the likelihood of suffering a stroke increased as the homocysteine levels increased. A total of 825 noncardioembolic ischemic stroke patients whose plasma concentrations of total homocysteine were measured and.

Murthy department of neurology, the institute of neurological sciences, care hospital, hyderabad, india ischemic stroke has a high prevalence and high burden of illness. The incidence of hyperhomocysteinemia is higher in ischaemic stroke cases than that in agesex matched healthy controls. Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. To evaluate clinical, biochemical, and neurophysiological findings in patients with ischemic stroke with and without hyperhomocysteinemia. When the levels get too high, it increases your risk of heart disease, heart attack, and stroke. We report a case of 18yearold female presented with recurrent episodes of headache and vertigo. Moyamoya disease is a chronic progressive cerebrovascular disease characterized by bilateral occlusion or stenosis of arteries around circle of willis.

The oc currence and development of csvd are related to age, gender, hypertension, hyperglycemia, hyperlipidemia, smoking, etc. The heavy intake of nitrous oxide in the form of energy drinks could be a risk factor for hyperhomocysteinemia and, thus, thrombotic events like ischemic stroke. Know the causes, symptoms, treatment and diagnosis of. Association between hyperhomocysteinemia and stroke with. Pdf hyperhomocysteinemia and hypofibrinolysis in young.

In addition to making people prone to blood clots, hyperhomocysteinemia will also increase the risk of birth defects, dementia e. Pdf epidemiologic studies have identified hyperhomocysteinemia as a possible risk factor for atherosclerosis. The balance of evidence from observational studies suggests that elevated homocysteine levels are associated with increased risk of carotid artery disease and stroke. The objective of this study was to determine the prevalence and shortterm impact of hyperhomocysteinemia in nigerians with acute ischaemic stroke. Stroke in young patients with hyperhomocysteinemia due to cystathionine betasynthase deficiency.

Hyperhomocysteinemia has been shown to be a mild independent risk factor for premature atherosclerosis, and there is evidence of an increased rate of peripheral vascular occlusive disease, myocardial infarction, and stroke. Homocysteine, mthfr 677ct polymorphism, and ischemic. Hyperhomocysteinemia, mthfr 677ct polymorphism, and stroke. Normally, these metabolites are not found in appreciable quantities in blood or urine. To study homocysteine levels in patients with ischemic stroke and compare it with age and sexmatched controls. Hyperhomocysteinemia in ischaemic stroke patients has as been determined as. Homocysteine hcy is a toxic, sulfurcontaining intermediate of methionine metabolism. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Hyperhomocysteinemia is a potentially modifiable risk factor for stroke, and may have a negative impact on the course of ischaemic stroke. Although the visp vitamin intervention for stroke prevention trial showed that highdose multivitamin therapy did not help in preventing recurrent stroke, the control agent used in the trial contained small doses of vitamin b6, b12, and folic acid, and the. Hyperhomocysteinemia induced oxidative stress may occur as a result of decreased expression andor activity of key antioxidant enzymes as well as increased enzymatic generation of superoxide anion the precursor.

The association between mtrr a66g polymorphism and promoter methylation with is in patients with hhcy is have also been uncertain. A significant benefit in secondary prevention is not yet proven. Stroke in young patients with hyperhomocysteinemia due to. Although little is known about hcys plasmatic modifications in the acute phase of cerebrovascular diseases, a significant increase of homocysteine blood level in patients with stroke has been observed, which was enough to be considered as a. Hyperhomocysteinemia is one of the modifiable risk factor among causes of ischemic stroke in young. Vitamins are necessary in the metabolism of homocysteine. Hyperhomocysteinemia, ischemic stroke, and bvitamin treatment. Homocysteinemia in ischemic stroke among young adults. Hyperhomocysteinemia, alone or with other thrombophilic risk factors, may be associated with vascular occlusive pathology underlying varied clinical presentations. The high level of homocysteine is led to due to deficiency of vitamins like b6, folic acid or b9 or b9 since in several chemical reactions involves homocysteine.

Hyperhomocysteinemia, folateo and b12 vitamin in iranian. This study was conducted to investigate the role of different homocysteine metabolismrelated vitamin hmrv levels in the correlation between hyperhomocysteinemia hhcy and ischemic stroke is subtypes. Hyperhomocysteinemia is a risk factor for both myocardial ischemia and ischemic stroke, and alcoholics often have elevated blood homocysteine levels secondary to deficiency of folate, pyridoxine, or cobalamin. Association of hyperhomocysteinemia with stroke recurrence. Stroke in young patients with hyperhomocysteinemia. This casecontrol pilot study aims to determine the prevalence and degree of hyperhomocysteinemia among malaysian patients with ischaemic strokes.

Homocysteine is an amino acid produced when proteins are broken down. Hyperhomocysteinemia as a risk factor for ischemic stroke bioline. Features, symptoms, and neurophysiological findings in. Frontiers hyperhomocysteinemia as a risk factor and. Homocysteine is metabolized by one of two pathways. Moderate hyperhomocysteinemia occurs in 57% of general population, and is associated in the third and fourth deceny of life with premature coronary disease, stroke, arterial and venous.

It is believed that high blood levels of homocysteine can damage the lining of blood vessels. Homocysteine, hypertension and stroke journal of human. Modest elevations of plasma homocysteine are independently associated with an increased incidence of venous thrombosis and arterial atherothrombotic diseases, including myocardial infarction and stroke. Stroke is the second leading cause of death worldwide and the leading cause of adult disability in many countries. Data from the multicenter chinese stroke study showed that hyperhomocysteinemia are more closely related to stroke recurrence among participants with the mthfr tt genotype. Homocysteine is an amino acid produced by the body and also is in your blood. Hyperhomocysteinemia in patients with acute ischaemic. Pdf relationship between homocysteine and ischemic stroke. Hyperhomocysteinemia an overview sciencedirect topics. Clinical and biochemical phenotypes and genetic features of three unrelated patients with premature stroke and severe hyperhcy due to cystathionine betasynthase cbs deficiency are described.

Because of the low cost and safety of the therapy, the american heart and stroke association advises to treat patients with a stroke and hyperhomocysteinemia daily with 0,4 mg folic acid, 2,4 mu g vitamin 12 and 1, 7 mg vitamin b6. Hyperhomocysteinemia is a less welldocumented modifiable risk factor 5, that correlated with vascular disease, including stroke. Successful treatment of brain ischemia with supplementation therapy in a patient with hyperhomocysteinemia thyroid disease. Hyperhomocysteinemia, a new independent risk factor for atherosclerotic vascular disease, has been described in the last ten years. A common cause of mildtomoderate hyperhomocysteinemia is a ct substitution at position 677 of the 5,10methylenetetrahydrofolate reductase mthfr gene, a key enzyme in homocysteine hcy metabolism. To answer the question directly, hyperhomocysteinemia is a significant risk factor for ischemic stroke as well as vascular events after the initial stroke stroke recurrence, ischemic heart. Stroke is the leading cause of mortality and disability in china and the second leading cause of death in the world. He was also found to have hyperhomocysteinemia, which has been implicated as a risk factor for spontaneous cervical. Associations of mtrr a66g polymorphism and promoter. On cerebral angiography, the patient was diagnosed to have moyamoya disease. Hhcys is also considered an independent risk factor for peripheral vascular diseases such as stroke 35, 60. The controversial role of homocysteine in neurology.

Homocystinuria homocystinuria is a disorder of methionine metabolism, leading to an abnormal accumulation of homocysteine and its metabolites homocystine, homocysteinecysteine complex, and others in blood and urine. Accumulating data suggest elevated total serum homocysteine thcy is associated with an increased risk of coronary heart disease and stroke. What is hyperhomocysteinemia, know its causes, symptoms. We evaluated the relationship between hyperhomocysteinemia and methylenetetrahydrofolate reductase mthfr c677t polymorphism and smallvessel disease svd and atherosclerotic largevessel disease lvd in stroke patients. The prevalence of hyperhomocysteinemia is almost twice as high when based on homocysteine measurements taken after a methionine load as when based solely on fasting levels. A high homocysteine level, also called hyperhomocysteinemia, can contribute to arterial damage and blood clots in your blood. The jury is still out j mk murthy department of neurology, the institute of neurological sciences, care hospital, hyderabad, india. Background and purposetotal homocysteine thcy levels are associated with secondary vascular events and mortality after stroke. Prevention remains the optimal strategy to reduce the. The role of hyperhomocysteinemia as it relates to stroke in africans is still uncertain.

All young patients with ischemic stroke need to be investigated for homocysteine level, and treatment of hyperhomocysteinemia may help in preventing recurrence of. We aim to investigate the association between the mtrr polymorphism and methylation with is in hhcy patients. Hyperhomocysteinemia results from an inhibition of the remethylation pathway or from an inhibition or a saturation of the transsulfuration pathway of homocysteine metabolism. Hyperhomocysteinemia in patients with acute ischaemic stroke in. Methods this prospective study was conducted on young ischemic stroke patients in pakistan atomic energy commission general hospital, islamabad. Our case illustrates the previously established association between the inhaled intake of nitrous oxide and the increased risk of ischemic stroke in a young male patient. Hyperhomocysteinemia, mthfr 677ct polymorphism, and. Homocysteine and neurologic disease neurology jama.

Role of homocysteine in the ischemic stroke and development of. Causes can be genetic homocystinuria or alcoholism. Elevated total homocysteine levels in acute ischemic stroke are. Coronary vascular disease, stroke, recurrent pregnancy loss, and deep vein thrombosis are some of the presentations. A 28yearold man presented with an acute spontaneous dissection of the left posterior communicating artery with associated ipsilateral thalamic and internal capsular infarctions. Pdf hyperhomocysteinemia is generally acknowledged as a treatable risk factor for atherotrombotic diseases, but a causal relationship between both is. Three hundred and fortyeight is patients manifesting different vascular subtypes were subclassified on the basis of hmrv deficiencies.

Objective to find out the frequency of hyperhomocysteinemia in young ischaemic stroke patients and its relationship with early morbidity and mortality. Homocysteine and vitamin therapy in stroke prevention and treatment. Changes in total homocysteine levels after acute stroke and. Clinical studies suggested that acute ischemic stroke patients with hyperhomocysteinemia hhcy are at an increased risk for early neurological deterioration, 4 longterm mortality, 5 and poor function outcome,6, 7 whereas other studies observed no association between hhcy and stroke outcome. Ischaemic stroke patients of age hyperhomocysteinemia. Hyperhomocysteinemia is associated with atherothrombotic disease and venous thrombosis. Positive risk factors included smoking and family history of ischemic heart disease. Recreational nitrous oxide abuse causing ischemic stroke. Hyperhomocysteinemia in a patient with moyamoya disease. Homocysteine, smallvessel disease, and atherosclerosis. Although little is known about hcys plasmatic modifications in the acute phase of cerebrovascular diseases, a significant increase of homocysteine blood level in patients with stroke has been observed. Hyperhomocysteinemia hhcy, as a consequence of impaired hcy metabolism or defects in crucial cofactors that participate in its recycling, is assumed as an independent human stroke risk factor.

1242 1057 449 958 990 1053 124 462 1540 1482 30 493 915 970 1331 826 280 402 1322 1570 1147 936 439 1037 1302 447 1595 625 678 145 1330 824 472 270 937 543 368 1237 468